Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

PT-141 vs Melanotan II: Which Is Right for You?

Quick verdict PT-141 (Vyleesi) is FDA-approved for hypoactive sexual desire disorder in premenopausal women and is safe when used as directed. Melanotan II is not FDA-approved, has no legal pathway, and carries significant safety concerns including nausea, flu

This comparison does not assign a generated winner or score.

  • Quick verdict
  • PT-141 (Vyleesi) is FDA-approved for hypoactive sexual desire disorder in premenopausal women and is safe when used as directed. Melanotan II is not FDA-approved, has no legal pathway, and carries significant safety concerns including nausea, flushing, and potential melanoma risk. Do not use Melanotan II; choose PT-141 if indicated.
More references

Related material

Comparison

Effectiveness Comparison

Clinical efficacy data for PT-141 comes from well-controlled Phase III trials, while Melanotan II evidence relies primarily on small-scale studies and anecdotal reports[27]. The R…

View details →
Comparison

Cost Comparison

PT-141 pricing reflects its FDA-approved status and brand-name manufacturing[78]. The brand name Vyleesi costs approximately $400-800 per dose through retail pharmacies, translati…

View details →
Comparison

Side-by-Side Comparison

Class Melanocortin Receptor Agonist Melanocortin Peptide FDA Status FDA Approved Research Use Primary Uses Sexual Wellness Tanning, Sexual Wellness Administration Subcutaneous Inj…

View details →